Detalles de la búsqueda
1.
A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.
Haemophilia
; 25(6): 979-987, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31515851
2.
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Ann Rheum Dis
; 77(3): 348-354, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191819
3.
Effect of monthly intravenous ibandronate injections on vertebral or non-vertebral fracture risk in Japanese patients with high-risk osteoporosis in the MOVER study.
J Bone Miner Metab
; 35(1): 58-64, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26614597
4.
Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER study.
J Bone Miner Metab
; 34(6): 678-684, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26462480
5.
A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia.
BMC Psychiatry
; 16: 66, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26980460
6.
Increased bone mineral density with monthly intravenous ibandronate contributes to fracture risk reduction in patients with primary osteoporosis: three-year analysis of the MOVER study.
Calcif Tissue Int
; 95(6): 557-63, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25377907
7.
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study.
BMJ Open
; 12(6): e059667, 2022 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35697445
8.
Challenges on Multiple Endpoints in Clinical Trials: An Industry Survey in Japan.
Ther Innov Regul Sci
; 54(3): 528-533, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33301137
9.
Multiplicity Adjustment and Sample Size Calculation in Clinical Trials with Multiple Endpoints: An Industry Survey of Current Practices in Japan.
Ther Innov Regul Sci
; 54(5): 1097-1105, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32030692
10.
Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study.
J Hypertens
; 27(2): 357-64, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19155790
11.
Challenges on Multiple Endpoints in Clinical Trials: An Industry Survey in Japan.
Ther Innov Regul Sci
; : 2168479019855994, 2019 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31213076
12.
Current Practice on Multiplicity Adjustment and Sample Size Calculation in Multi-arm Clinical Trials: An Industry Survey in Japan.
Ther Innov Regul Sci
; 50(6): 846-852, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231736
Resultados
1 -
12
de 12
1
Próxima >
>>